Endologix, Inc. (ELGX) Anticipates Reporting Significant Revenue Growth for 2008; Issues 2009 Guidance
Endologix, Inc. announced that it is expecting the revenue generated during last year to total approximately $37.6 million, a 35% increase from 2007 revenue of $27.8 million. The company anticipates reporting Q4 2008 revenue of approximately $10.7 million, up 35% from total product revenue of $7.9 million reported for Q4 2007. "We attribute our strong 2008 sales growth and ability to exceed our revenue guidance to the increasing success of our sales force initiatives, the introduction of new products and increased physician adoption of our Powerlink System," said John McDermott, Endologix president and chief executive officer. "Our recently launched suprarenal…